Name | XL-001 |
---|
Description | XL-001 (XL001) is a novel specific CB2 inverse agonist with Ki of 0.5 nM; inhibits in a dose-dependent fashion the fibrogenic response induced by CB2 overexpression, CB2 agonist or transforming growth factor-β1, ameliorates kidney injury, fibrosis and inflammation in both the obstruction and ischemia/reperfusion models. |
---|---|
References | References 1. Zhou L, et al. Kidney Int. 2018 Aug 6. pii: S0085-2538(18)30397-1. View Related Products by Target Cannabinoid Receptor |
Molecular Formula | C25H30N2O3S |
---|---|
Molecular Weight | 438.586 |